If youre wondering which one does it better, youre not alone
However, in November 2025, the Trump Administration announced TrumpRx, an initiative similar to GoodRx, to lower the price of GLP-1s to $245 per month for patients covered by Medicaid and CHIP and $50 month for Medicare patients if states opted in
Ongoing monitoring should include thyroid function testing at appropriate intervals, particularly in patients experiencing significant weight loss or after tirzepatide dose increases
As for the money-back guarantee, 30 days seems to be about as generous as any of these companies get, and its not enough time to meaningfully test out semaglutide
It means the system is real, responsive, and worth supporting